X

Articles

25Jan

CTS implements Ortho VIP Viral Marker Testing Platform

0 Comments | | Return |
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the Prism to the VIP is one of the most significant changes we have made in the past three years. We implemented the new system through the dedication and extraordinary effort of everyone across the enterprise. Congratulations on this important success!

Related

CTS Tampa Implementation date change for Ultrio Elite

CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...

Read More >

CTS conversion to the Ortho VERSEIA Integrated Processor (VIP) in January 2021

After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...

Read More >

Seasonal Monitoring for WNV to begin June 1, 2019

Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...

Read More >

CTS Charlotte Lab Implements WNV Testing on the Panther

CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...

Read More >

Creative Testing Solutions and Grifols Forge New Testing Partnership

Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...

Read More >

Update on the Ortho Conversion

At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...

Read More >

Subscribe here to receive CTS updates!

Name